Abstract
The corpus callosum is the largest white matter commissural pathway, important for inter-hemispheric communication. Previous studies suggest that structural alteration of the corpus callosum occurs after a preterm birth in the neonatal period that lasts across childhood, adolescence and young adulthood. The present study aims to unravel corpus callosum structural characteristics across development in very preterm children and adolescents aged 6 to 15 years, as well their associations with general intellectual, executive and social functioning. Neuropsychological assessments of general intellectual, executive and social functioning as well as T1-weighted and multi-shell diffusion MRI were collected in 79 very preterm and 46 full term controls aged 6 to 15 years. Volumetric, diffusion tensor imaging (DTI) and neurite orientation dispersion and density imaging (NODDI) measures were extracted on 7 portions of the corpus callosum using TractSeg. A multivariate data-driven approach (partial least squares correlation) and an age normative modelling approach were used to explore associations between callosal characteristics and neuropsychological outcomes. The very preterm and full-term control group showed similar trends of white-matter maturation over time, i.e., increase FA and reduced ODI, in all segments of the corpus callosum, that was associated with increase in general intellectual functioning. However, using age-related normative modelling of volumetric, tensor and NODDI diffusion measures, findings show atypical pattern of callosal development in the very preterm group with reduced callosal maturation over time. Atypical developmental trajectory of callosal maturation was associated with poorer general intellectual and working memory functioning as well as with greater prematurity. The present study also illustrates how normative age modelling approach allows to shed new insight into neurodevelopmental trajectory in the VPT population and its association with functional outcomes.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by the Swiss National Science Foundation, No. 324730_163084 [PI: P.S. Huppi].
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by the Swiss Ethics Committees on research involving humans, ID: 2015-00175. Written informed consent was obtained from the principal caregiver and from the participant.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Ethical restrictions prevent us from making anonymised data available in a public repository. Data may be available from the Royal Children s Hospital Data Access/Ethics Committee for researchers to researchers who meet the criteria for access to confidential data by direct request to: Petra.Huppi@hcuge. There are restrictions on data related to identifying participant information and appropriate ethical approval is required prior to release. Only de-identified data will be available.